Gene therapy of Parkinson's disease using adeno-associated virus (AAV) vectors

Journal of Neural Transmission, Supplement

Volumn , Issue 58, 2000, Pages 181-191

  Ozawa, K ^a   Fan, D S ^a   Shen, Y ^a   Muramatsu, S ^a   Fujimoto, K ^a   Ikeguchi, K ^a   Ogawa, M ^a   Urabe, M ^a   Kume, A ^a   Nakano, I ^a  

^a JICHI MEDICAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

AROMATIC LEVO AMINO ACID DECARBOXYLASE; DOPAMINE; GLIAL CELL LINE DERIVED NEUROTROPHIC FACTOR;

ADENO ASSOCIATED VIRUS; CONFERENCE PAPER; DOPAMINERGIC NERVE CELL; GENE TARGETING; GENE THERAPY; NONHUMAN; PARKINSON DISEASE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SUBSTANTIA NIGRA;

EID: 0033709475     PISSN: 03036995     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-3-7091-6284-2_15     Document Type: Conference Paper

References (56)

1. Mesencephalic dopaminergic neurons protected by GDNF from axotomy-induced degeneration in the adult brain
2. Intrastriatal injection of an adenoviral vector expressing glial-cell-line-derived neurotrophic factor prevents dopaminergic neuron degeneration and behavioral impairment in a rat model of Parkinson disease
3. Highly efficient and sustained gene transfer in adult neurons with a lentivirus vector
4. Dopaminergic neurons protected from degeneration by GDNF gene therapy
5. Efficient transduction of human neurons with an adeno-associated virus vector
6. Long-term behavioral recovery in Parkinson's rats by an HSV vector expressing tyrosine hydroxylase
7. In vivo expression of therapeutic human genes for dopamine production in the caudates of MPTP-treated monkeys using an AAV vector
8. Prevention of dopaminergic neuron death by adeno-associated virus vector-mediated GDNF gene transfer in rat mesencephalic cells in vitro
9. Behavioral recovery in 6-hydroxydopamine-lesioned rats by cotransduction of striatum with tyrosine hydroxylase and aromatic L-amino acid decarboxylase genes using two separate adeno-associated virus vectors
10. Recombinant adeno-associated virus for muscle directed gene therapy
11. Survival of implanted fetal dopamine cells and neurologic improvement 12 to 46 months after transplantation for Parkinson's disease
12. Functional recovery in parkinsonian monkeys treated With GDNF
13. An HSV-1 vector expressing tyrosine hydroxylase cause production and release of 1-DOPA from cultured rat striatal cells
14. Stable gene transfer and expression of human blood coagulation factor IX after intramuscular injection of recombinant adeno-associated virus
15. Long-term correction of canine hemophilia B by gene transfer of blood coagulation factor IX mediated by adeno-associated viral vector
16. Isolation and characterization of a cDNA clone encoding human aromatic 1-amino acid decarboxylase
17. Significant behavioral recovery in Parkinson's disease model by direct intracerebral gene transfer using continuous injection of a plasmid DNA-liposome complex
18. Packaging cells based on inducible gene amplification for the production of adeno-associated virus vectors
19. Immuno-cytochemical localization of aromatic 1-amino acid decarboxylase
20. Long-term correction of ral model of Parkinson's disease by gene therapy
21. Gene therapy for neuromuscular disorders
22. Gene therapy and the brain
23. Interleukin 3 as atrophic factor for central cholinergic neurons in vitro and in vivo
24. DOPA-decarboxylation in the striata of rats with unilateral substantia nigra lesions
25. Regulation of dopamine production by genetically modified primary fibroblasts
26. Long-term gene expression and phenotypic correction using adeno-associated virus vectors in the mammalian brain
27. Isolation of a novel cDNA clone for human tyrosine hydroxylase: Alternative RNA splicing produces four kinds of mRNA from a single gene
28. Gene delivery to skeletal muscle results in sustained expression and systemic delivery of a therapeutic protein
29. Prospects for the use of adeno-associated virus as a vector for human gene therapy
30. An adenovirus vector for gene transfer into neurons and glia in the brain
31. GDNF: A glial cell line-derived neurotrophic factor for midbrain dopaminergic neurons
32. Adeno-associated virus-mediated gene transfer to the brain: Duration and modulation of expression
33. Generation of DOPA-producing astrocytes by retroviral transduction of the human tyrosine hydroxylase gene: In vitro characterization and in vivo effects in the rat Parkinson model
34. Midbrain injection of recombinant adeno-associated virus encoding rat glial cell line-derived neurotrophic factor protects nigral neurons in a progressive 6-hydroxydopamine-induced degeneration model of Parkinson's disease in rats
35. Characterization of intrastriatal recombinant adeno-associated virus-mediated gene transfer of human tyrosine hydroxylase and human GTP-cyclohydrolase I in a rat model of Parkinson's disease
36. Use of conditionally immortalized neural progenitors for transplantation and gene transfer to the CNS
37. Cloning and structural organization of the gene encoding the mouse glial cell-line-derived neurotrophic factor, GDNF
38. Adeno-associated virus vectors can be efficiently produced without helper virus
39. Use of adeno-associated virus as a general transduction vector for mammalian cells
40. Immunofluorescent and biochemical studies on tyrosine hydroxylase and dopamine-beta-hydroxylase of the bullfrog sciatic nerves
41. Molecular biology of dopamine systems
42. In vivo gene delivery and stable transduction of nondividing cells by a lentiviral vector
43. The use of heterologous promoters for adeno-associated virus (AAV) protein expression in AAV vector production
44. Efficient production of adeno-associated virus vectors using split-type helper plasmids
45. Glial cell line-derived neurotrophic factor but not transforming growth factor β3 prevents delayed degeneration of nigral dopaminergic neurons following striatal 6-hydroxydopamine lesion
46. Persistent and therapeutic concentrations of human factor IX in mice after hepatic gene transfer of recombinant AAV vectors
47. Correction of hemophilia B in canine and murine models using recombinant adenoassociated viral vectors
48. Unilateral transplantation of human fetal mesencephalic tissue into the caudate nucleus of patients with Parkinson's disease
49. Viral gene delivery selectively restores feeding and prevents lethality of dopamine-deficient mice
50. Striatal neurons with aromatic 1-amino acid decarboxylase-like immunoreactivity in the rat
51. Protection and repair of the nigrostriatal dopaminergic system by GDNF in vivo
52. GDNF: A cytokine at the interface of TGF-β and neurotrophins
53. Gene therapy - Promises, problems and prospects
54. Role of aromatic 1-amino acid decarboxylase for dopamine replacement by genetically modified fibroblasts in a rat model of Parkinson's disease
55. Adeno-associated virus vector-mediated transgene integration into neurons and other nondividing cell targets
56. Multiply attenuated lentiviral vector achieves efficient gene delivery in vivo